Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001035856 | SCV001199195 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2019-02-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the 349 amino acid residue in MSH2. Other variant that disrupts this residue have been observed in individuals with MSH2-related conditions (PMID: 21239990, 27606285, 24278394), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acids is currently unknown. This variant has not been reported in the literature in individuals with MSH2-related conditions. This variant is not present in population databases (ExAC no frequency). This variant, c.1038_1049del, results in the deletion of 4 amino acids of the MSH2 protein (p.Lys347_Leu350del), but otherwise preserves the integrity of the reading frame. |